Skip to content

Agios Pharmaceuticals AGIO Change in Inventories

Change in Inventories at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$14M-108%
Pfizer logo
PfizerPFE
-$140.25M-166%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$97.7M-41.5%
Incyte logo
IncyteINCY
$12.23M-57.2%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
-$44.49M-283%
Precigen logo
PrecigenPGEN
$4.88M

Other financials

Income statement

See full
Revenue$20.7M+138%
Gross profit$19.4M+154%
Operating income-$110.0M-3.2%
Net income-$99.1M-11.0%
EPS (diluted)-$1.69-9.0%

Balance sheet

See full
Cash & equivalents$113.6M+43.9%
Total debt$35.7M-32.5%
Total equity$1.1B-24.4%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow-$118.9M-6.7%
CapEx$769.0K+0.4%
Free cash flow-$119.7M-6.6%

Valuation

See full
Market cap$2.12B+18.1%
Enterprise value$2.04B+15.2%
P/S32.1×-16.4×

Profitability

See full
Gross margin90%+2.5pp
Operating margin-720%-204pp
Net margin-639.8%
FCF margin-582.5%-185pp

Returns & leverage

See full
Return on equity-32.8%
Debt / equity0.0×
Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agios Pharmaceuticals's change in inventories?
Agios Pharmaceuticals (AGIO) reported change in inventories of $2.17M in Q1 2026.
How has Agios Pharmaceuticals's change in inventories changed year-over-year?
Agios Pharmaceuticals's change in inventories increased by 8.9% year-over-year, from $1.99M to $2.17M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.